Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept

NCT05610488 is registered in ClinicalTrials.gov with Vista Klinik as lead sponsor.

NCT NCT05610488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05610488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept
Lead sponsor
Vista Klinik
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2022
Completion date
December 31, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema